SIDRANSKY DAVID 4
4 · Ayala Pharmaceuticals, Inc. · Filed Jun 15, 2022
Insider Transaction Report
Form 4
SIDRANSKY DAVID
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-13+12,500→ 12,500 totalExercise: $1.63Exp: 2032-06-12→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable on the earlier of (i) June 13, 2023 or (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date.